Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-001171

Director gave up 40,107 shares (to pay taxes)

  • Director acquired 31,780 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ezickson Elan Director 2019-12-31 Grant or award +31,780 111,994 D
Ezickson Elan Director 2019-12-31 Shares withheld for taxes −40,107 $4.72 $189,305 71,887 D
Loading xslF345X03/doc4.xml…